Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CAMEALE SMART

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1275799439
CMS profile
285231
Location
HARTFORD, CT

General Payments · PY2018–2024

$1,351.97

  • Reported across 79 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$336.50

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $336.50 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $416.59 26
PY2019 $560.60 35
PY2020 $21.02 1
PY2021 $17.26 1
PY2024 $336.50 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018201920202021 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $19.25 01/12/2024 Food and Beverage Undisputed 01/23/2026 1106120248 CMS
Amgen Inc. $14.55 02/12/2024 Food and Beverage Undisputed 01/23/2026 1117385315 CMS
AstraZeneca Pharmaceuticals LP $18.55 03/04/2024 Food and Beverage Undisputed 01/23/2026 1104512016 CMS
AstraZeneca Pharmaceuticals LP $20.45 03/04/2024 Food and Beverage Undisputed 01/23/2026 1104671243 CMS
AstraZeneca Pharmaceuticals LP $16.18 04/24/2024 Food and Beverage Undisputed 01/23/2026 1104432955 CMS
Bayer Healthcare Pharmaceuticals Inc. $22.89 02/14/2024 Food and Beverage Undisputed 01/23/2026 1086137733 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.89 03/14/2024 Food and Beverage Undisputed 01/23/2026 1086128476 CMS
Exact Sciences Corporation $24.85 05/08/2024 Food and Beverage Undisputed 01/23/2026 1114904830 CMS
GlaxoSmithKline, LLC. $20.32 04/15/2024 Food and Beverage Undisputed 01/23/2026 1116347444 CMS
GlaxoSmithKline, LLC. $17.50 08/27/2024 Food and Beverage Undisputed 01/23/2026 1115873297 CMS
GlaxoSmithKline, LLC. $27.35 09/19/2024 Food and Beverage Undisputed 01/23/2026 1115843196 CMS
Merck Sharp & Dohme LLC $18.89 03/19/2024 Food and Beverage Undisputed 01/23/2026 1141852943 CMS
Novo Nordisk Inc $20.43 02/28/2024 Food and Beverage Undisputed 01/23/2026 1097062143 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.12 02/14/2024 Food and Beverage Undisputed 01/23/2026 1137678013 CMS
Teva Pharmaceuticals USA, Inc. $28.64 03/21/2024 Food and Beverage Undisputed 01/23/2026 1151538175 CMS
Teva Pharmaceuticals USA, Inc. $28.64 05/02/2024 Food and Beverage Undisputed 01/23/2026 1151538207 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.